Veterinary Medicines

Nelio 2.5 mg Tablet for Cats

Authorised
  • Benazepril hydrochloride
Download as PDF

Product identification

Medicine name:
NELIO 2.5 MG TABLET FOR CATS
Nelio 2.5 mg Tablet for Cats
Active substance:
  • Benazepril hydrochloride
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Benazepril hydrochloride
    2.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Box with 18 strips (Aluminium/Aluminium) of 10 tablets
  • Box with 1 strip (Polyamide-Aluminium-Desicant/Aluminium) of 10 tablets
  • Box with 2 strips (Polyamide-Aluminium-Desicant/Aluminium) of 10 tablets
  • Box with 5 strips (Polyamide-Aluminium-Desicant/Aluminium) of 10 tablets
  • Box with 10 strips (Polyamide-Aluminium-Desicant/Aluminium) of 10 tablets
  • Box with 14 strips (Polyamide-Aluminium-Desicant/Aluminium) of 10 tablets
  • Box with 18 strips (Polyamide-Aluminium-Desicant/Aluminium) of 10 tablets
  • Box with 1 strip (Aluminium/Aluminium) of 10 tablets
  • Box with 14 strips (Aluminium/Aluminium) of 10 tablets
  • Box with 10 strips (Aluminium/Aluminium) of 10 tablets
  • Box with 5 strips (Aluminium/Aluminium)of 10 tablets
  • Box with 2 strips (Aluminium/Aluminium) of 10 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10815/031/002
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0178/002
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Finland
  • Germany
  • Hungary
  • Ireland
  • Italy
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)